News Focus
News Focus
icon url

bax

01/24/08 12:37 PM

#4669 RE: Noble Leslie Devotie #4667

Sand should be in jail. If I was rich, I'd hire a lawyer to go after him just for kicks. He stole 12 grand from me with his constant lies and misrepresentations.
icon url

stockmasterflash

01/24/08 3:02 PM

#4671 RE: Noble Leslie Devotie #4667

I got the same exact response from Lincare

They aren't shy about answering their email about it.

Subject: RE: Ingen Oxyview?
Date: Thu, 24 Jan 2008 14:07:40 -0500
From: "info" <1nfo@lincare.com> Add Mobile Alert
To: XXXXXXX


Mr. XXXXx,
No such agreement exists, and Lincare was not a party to the press
release you are referring to.

Thank you for your inquiry.

Sincerely,
Lincare Customer Service

-----Original Message-----
From: xxxxx
Sent: Thursday, January 24, 2008 12:59 PM
To: info
Subject: Ingen Oxyview?

Yesterday a struggling penny stock claimed Lincare had
signed a distribution contract to sell Oxyview? Is
this true?

Press release is below:

Any info you can provide would be

xxxxx


http://money.cnn.com/news/newsfeeds/articles/prnewswire/LAW12123012008-1
.htm

- Ingen Technologies Gets Green-Light From Lincare
Corporation -
PR Newswire
Lincare is the largest US Home Oxygen Supplier
January 23, 2008: 12:29 PM EST

YUCAIPA, Calif., Jan. 23 /PRNewswire-FirstCall/ --
Ingen Technologies, Inc. , a medical device
manufacturer, announced today that it has engaged an
Oxyview(R) purchase agreement with Lincare Corporation
for their more than 1000 locations in the United
States.

Scott Sand, CEO and Chairman, states; "Lincare
Corporation approved the US delivery of Oxyview(R) on
January 16, 2008. Since Thursday last week we have
sent out a fax-blast to all of the Lincare locations,
and recently started receiving the first 6 purchase
orders for 6 of their locations. Each order is for 10
or more units. We are expecting to deliver over a
million units each year to Lincare patients. This
would represent more than $8M in annual revenues for
Ingen Technologies."

Lincare Corporation has been synonymous with
state-of-the-art oxygen systems since 1965. Their
reputation for 24-hour, seven-days-a-week
responsiveness, expert service representatives, and
professional staff testifies to Lincare's absolute
commitment to provide the very best quality home
respiratory service available. Lincare responds to the
needs of every patient individually by providing the
oxygen system most appropriate for his or her
lifestyle. Oxygen concentrators, stationary and
portable liquid oxygen systems, and high pressure
cylinders are provided according to the physician's
prescription and with consideration for the activity
level of each patient. Lincare regularly monitors how
well each respiratory patient follows the prescribed
course of treatment, ensuring compliance with liter
flow and hours of use. Regularly monitoring patient
compliance increases the likelihood that patients will
receive the maximum benefit from the prescribed
therapy.

"Ingen has been fortunate enough to attract the
interest and distribution power of the world's largest
distributors of home oxygen supplies. Invacare Supply
Group and Lincare Corporation represent over 95% of
the US and World markets for respiratory care
products. This affords the Company a channel to place
Oxyview(R) and OxyAlert(R) with annual deliveries of
over 20 million patients in the home setting and
another 40 million patients in hospitals and skilled
nursing facilities," stated Thomas Neavitt, CFO.

About Ingen Technologies, Inc.

Ingen Technologies, Inc., a Georgia Corporation, is a
medical device manufacturer, Certified through the
Department of Health Services, and a publicly traded
company trading under NASDAQ OTC: IGTG. The Company
has been in business since 1999. Ingen received FDA
clearance last year and offers products for the
respiratory markets. The Oxyview(R) and OxyAlert(R)
are proprietary products that increase accuracy of
medical care and prevent unnecessary medical costs
associated with today's healthcare industry. Ingen
owns a variety of intellectual biotech property
including several US patent(s) and several Foreign
Patent(s) either issued or pending in the US, Japan,
European Communities and People's Republic of China.

For more information, visit: www.ingen-tech.com

Contact: Scott R. Sand, C.E.O & Chairman
Ingen Technologies, Inc. -
Administrative Office
35193 Avenue "A", Suite-C
Yucaipa, California 92399
Phone: (909) 790-7180
Fax: (909) 795-6340
Email: Info@ingen-tech.com

A Member of the Better Business Bureau
A Member of the Chamber of Commerce
A Licensed Business in the City of Yucaipa
A Certified Manufacturer with FDA/DHS

Safe Harbor for Forward-Looking Statements: This news
release includes forward-looking statements. While
these statements are made to convey to the public the
company's progress, business opportunities and growth
prospects, readers are cautioned that such
forward-looking statements represent management's
opinion. Whereas management believes such
representations to be true and accurate based on
information and data available to the company at this
time, actual results may differ materially from those
described. The company's operations and business
prospects are always subject to risk and
uncertainties. Important factors that may cause actual
results to differ are and will be set forth in the
company's periodic filings with the U.S. Securities
and Exchange Commission.
icon url

stockmasterflash

01/25/08 1:16 PM

#4679 RE: Noble Leslie Devotie #4667

Has anyone tried calling Sand?

Surely there must be some misunderstanding here.

I mean how do you reconcile Sand claiming Lincare is a client and Lincare claiming that just ain't so????

sand has a duty to his shareholders to either refute Lincare's denials or come clean about what he REALLY was trying to say (maybe:I sent 60 Oxyviews for Lincare to test drive and they didn't refuse delivery??)